Breast cancer

11 December 2015

Researchers focus on risk factors for leukaemia after breast cancer treatment

Scientists looked at 88 breast cancer survivors with treatment-related leukaemia and found that many had a personal and family history of cancer, suggesting a genetic susceptibility to cancer.

0

Researchers say they're zeroing in on factors that may increase the risk of leukaemia after breast cancer treatment.

The findings are a step forward in determining ways to prevent this complication in breast cancer survivors.

Inherited genetics

While the breast cancer treatments target malignant cells, they can also affect healthy cells and could increase the risk of leukaemia later, the researchers said.

Read: Gene Mutation Seems to Make a Leukaemia More Deadly 

The scientists looked at 88 breast cancer survivors with treatment-related leukaemia and found that many had a personal and family history of cancer, suggesting a genetic susceptibility to cancer.

Also, 20 percent of the women had an inherited gene mutation that increases the risk of breast cancer, according to the study published in the journal Cancer.

"The findings justify a long-term, follow-up study of women with and without inherited breast cancer gene mutations who are treated with similar therapy for breast cancer," said study leader Dr Jane Churpek, from the University of Chicago.

Read: Decoding breast cancer

"This would enable us to understand how these genes impact therapy-related leukaemia risk, and whether specific treatments come with higher risks based on a woman's inherited genetics," Churpek said in a journal news release.

Doctors could then have patient-specific conversations about the possible risks and benefits of chemotherapy and radiation treatments for breast cancer, she added.

Read: Leukaemia meds vs ovarian cancer

It can be difficult to determine whether leukaemia in breast cancer survivors is or is not treatment-related, Dr Judith Karp and Dr Antonio Wolff, from Johns Hopkins University School of Medicine in Baltimore, noted in an accompanying journal editorial.

"Existing familial cancer registries that are prospectively following breast cancer patients and their families are uniquely positioned to ascertain the true frequency of subsequent leukaemias and their associations with the therapies received," they wrote.

Read more:

Antidepressant shows promise as cancer treatment  

Immune-system therapy may help leukaemia 

Growing up on a farm ups cancer risk

Copyright © 2016 HealthDay. All rights reserved.

 

Ask the Expert

Breast cancer expert

Dr Gudgeon qualified in Birmingham, England, in 1968. She has more than 40 years experience in oncology, and in 1994 she founded her practice, Cape Breast Care, where she treats benign and malignant breast cancers. Dr Boeddinghaus obtained her qualification at UCT Medical School in 1994 and her MRCP in London in 1998. She has worked extensively in the field of oncology and has a special interest in the hormonal management of breast cancer. She now works with Dr Gudgeon at Cape Breast Care. Read more.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules